Published in Medical Letter on the CDC and FDA, November 19th, 2006
According to a report from the United States, "The rate of substance-use disorders in patients with mental illnesses within the psychotic spectrum, such as schizophrenia, schizo-affective disorder, and bipolar disorder, is higher than the rate observed in the general population and is associated with significant morbidity and mortality. Although there are currently three medications approved by the U.S. Food and Drug Administration for the treatment of alcohol dependence, no medications have been approved for the specific treatment of dually...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.